Tag: Lutetium (177Lu) oxodotreotide

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Lutetium (177Lu) oxodotreotide

POINT Biopharma Signs Exclusive License Agreement with CanProbe for the Commercialization of ...

Added to Collection on: 2021-01-12 12:00:00

Tags for this article:

Radiopharmaceuticals
Chemistry
Physical sciences
Health sciences
Orphan drugs
Chelating agents
Macrocycles
DOTA-TATE
Lutetium (177Lu) oxodotreotide
Advanced Accelerator Applications
POINT Biopharma Inc.

Click the tags to see associated articles and topics

View Article Details
Lower dose, less toxic radiopharmaceutical produces better outcomes

Added to Collection on: 2021-03-09 15:33:23

Tags for this article:

Medicine
Physical sciences
Chemistry
Radiopharmaceuticals
Medical physics
Chelating agents
Macrocycles
Orphan drugs
Peptide receptor radionuclide therapy
Neuroendocrine tumor
Lutetium (177Lu) oxodotreotide
Radiation therapy

Click the tags to see associated articles and topics

View Article Details
Neuroendocrine Tumors Pipeline Drugs Analysis Report (2023 Updates) - Digital Journal

Added to Collection on: 2023-12-14 18:41:07

Tags for this article:

Pancreatic cancer
Neuroendocrine tumor
Neuroendocrinology
Paltusotine
Pancreatic neuroendocrine tumor
Lutetium (177Lu) oxodotreotide
Boehringer Ingelheim
Celgene
Amgen
Neuroendocrine Tumors

Click the tags to see associated articles and topics

View Article Details
Novartis details first-line data for radiopharma drug Lutathera | BioPharma Dive

Added to Collection on: 2024-01-20 05:21:53

Tags for this article:

Orphan drugs
Radiopharmaceuticals
Macrocycles
Chelating agents
Neuroendocrinology
Lutetium (177Lu) oxodotreotide
Neuroendocrine tumor
Octreotide
DOTA-TATE
Novartis
Somatostatin
Pancreatic neuroendocrine tumor

Click the tags to see associated articles and topics

View Article Details
Book a Demo